Infection Expert: Don't Rush to Change MRSA Protocols
Starting Oct. 1, 2016, CMS intends to include MRSA rates in its algorithm to determine value-based purchasing incentives.
Surely time will tell whether states will rush to change their laws in light of this new study. But Wright worries that might not be such good thing. Universal decolonization has some downsides, one of which is development of MRSA strains that resist mupirocin.
That's why his hospital no longer uses that strategy. Instead, it screens patients based on an electronic health record assessment of those at highest risk, which turns out to be 50% of all of its admissions, as well as all patients admitted to the ICU to comply with state law.
Rates at NorthShore's four hospitals are even better than what was published in the NEJM paper, he says. "We haven't done a formal analysis, but when I, our infectious disease physician and hospital epidemiologist looked at this study results, we said, we're not going to do this because we're doing better than they are."
Wright is concerned, however, that state legislatures will overreact. "The thing I'm going to go to bed worrying about tonight is the well-intentioned, well-meaning legislator who is sitting in front of a computer right now with a Word document open."
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- Proton Beam Therapy Poised for Growth in US
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- 4 Crucial Tactics for Reining in Healthcare Cost
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Targeting Self-Insured Populations
- How, and Why, to Recruit Male Nurses
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013